EpCAM has been reported to have oncogenic potential [13] and correlate with proliferation in cell lines [14]; however, it is downregulated during EMT [1], and EMT markers have been shown to be more important than epithelial markers e.g., cytokeratin in predicting cancer progression [15]. This evidence concerns the gene EPCAM and cancer.